Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma

Hepatitis C virus (HCV) infection is associated with the development of non-Hodgkin lymphomas. For aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), treatment of HCV infection is typically deferred in treatment-naive patients until after completion of lymphoma therapy [1, 2]. We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ewers, Evan C., Shah, Phalgoon A., Carmichael, Mark G., Ferguson, Tomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Id Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170491/
https://www.ncbi.nlm.nih.gov/pubmed/28018926
http://dx.doi.org/10.1093/ofid/ofw223
Descripción
Sumario:Hepatitis C virus (HCV) infection is associated with the development of non-Hodgkin lymphomas. For aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), treatment of HCV infection is typically deferred in treatment-naive patients until after completion of lymphoma therapy [1, 2]. We report a case of HCV-associated stage IV DLBCL successfully treated concurrently using chemoimmunotherapy and a sofosbuvir-based antiviral regimen.

Ejemplares similares